Health Policy & Regulatory

Get informed about health policies and regulations that set in motion the vision of future healthcare.  Read what our healthcare communications leaders internationally think about the ongoing developments in healthcare legislation, health reform, and more.  We encourage comments and discussions! Share your opinions and ideas to readers like yourself and our bloggers.

Recent Blog Posts

Nancy Hicks's picture

Money Does Not Buy the Best Healthcare


The old adage, “you get what you pay for” does[[wysiwyg_imageupload:126:]]
not apply to healthcare.  As noted in a Commonwealth Fund study recently released, the United States spends more on healthcare than 12 other industrialized countries – and it doesn’t seem that our care is any better.

The cost gap is substantial.  The U.S. spends nearly $8,000 per person on health services while the next most expensive countries – Norway and Switzerland – spend a little more than $5,000 per person. Read full post »

Raúl Torres's picture

What’s in a Name?


Editor’s Note – this post was co-authored by [[wysiwyg_imageupload:125:]]
former Ketchum Pleon London colleague Joanna Birch.

As the glory days of Big Pharma’s monster blockbusters hurtle towards extinction taking billions of dollars, pounds and Euros profit with them, their biosimilars are preparing to pick up the lost market share. While they have invested significant time and money to develop counter attack strategies, there is one very large barrier standing in their way: generics are cheap.

As we well know, the simple truth is that in comparison to branded medications, generics will always win on price. And strategies such as incentivizing physicians in many EU countries to ensure that generics comprise a significant percentage of their prescriptions are now common practice. Read full post »

Jeff Levine's picture

The Great Broccoli Debate: The Affordable Care Act Arguments Continue


Jeff Levine is an award-winning journalist who
was the medical correspondent for[[wysiwyg_imageupload:122:]] CNN for 17 years.  He has also worked on Capitol Hill for Senator Byron Dorgan, as Washington bureau chief for WebMD, and as a media specialist at Ketchum. A guest contributor to Health-E Minds, the following post represents Jeff’s perspective on the Affordable Care Act, based on his opinions generated during his many years of observing and reporting on these issues.
– Nancy Hicks, Senior Vice President, Associate Director, Ketchum North America Healthcare Practice


Winston Churchill remarked that you can count on Americans to do the right thing—after they’ve tried everything else.  However, considering the current debate over the Affordable Care Act, he might have added an asterisked addendum—*except when it comes to health care policy.

After being pummeled in arguments before the US Supreme Court observers are left to wonder if not the current law, then what “thing” would ultimately satisfy detractors of the current reform without alienating its proponents?  Read full post »

Alexander Watson's picture

National Health Services Reform Bill – More Painful than Passing a Stone


The National Health Services (NHS) Reform and Social Care Bill [[wysiwyg_imageupload:117:]]
completed its rocky journey through parliament on Tuesday night. The Bill is one of the most complex pieces of health legislation ever to go through the legislator process and will lead to the biggest programme of reform since the NHS was established over 60 years ago.

Of most relevance to UK patients is the provision for treatment and referral decisions to be made by General Practitioners (GPs) instead of by NHS managers. GPs will therefore be responsible for the commissioning of services in primary and secondary care (with the exception of a few major services such as maternity) and are consequently likely to be much more interested in extracting value and better outcomes across the patient pathway from diagnosis through to treatment and managed care. Read full post »

In: Health Policy & Regulatory   /   filed under: NHS
Diane R. Johnson, MPH's picture

The New Real World: Transparency and Innovation in Government


With the 24-hour news cycle, new and social [[wysiwyg_imageupload:109:]]
media at our fingertips, and even a presidential initiative on “transparency and open government” — federal agencies must adapt to this change in paradigm. The Food and Drug Administration (FDA) along with the Centers for Medicare & Medicaid Services (CMS) recently held a summit in Washington, DC, where its top policy makers engaged biotech and pharmaceutical executives in an open dialogue on driving pre- and post-regulatory approval and commercialization strategies for products coming to market. Read full post »